Characteristics, efficacy, and prognosis analysis of newly diagnosed marginal zone lymphoma.

ABSTRACT:

Objective

To retrospectively analyze the characteristics of newly diagnosed marginal zone lymphoma (MZL) patients, evaluate the efficacy of different treatment regimens, and explore prognostic factors in the era of immunotherapy.

Methods

We reviewed the clinical data of newly diagnosed MZL patients treated at the Department of Hematology, The First Hospital of Jilin University, from October 2013 to October 2023. Survival differences between groups were analyzed using the log-rank test, and prognostic factors were identified.

Results

A total of 265 newly diagnosed MZL patients were included, with a median age of 59 years (range 22-90). The most common pathological type was mucosa-associated lymphoid tissue (MALT) lymphoma, accounting for 66.0% of cases. Among the 147 M

SUBMITTER: Wang H 

PROVIDER: S-EPMC11456499 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature